The Scientist

» breast cancer

Most Recent

image: Cancer Research Advocate Dies

Cancer Research Advocate Dies

By | March 5, 2013

A champion of breast cancer awareness in the African-American community passes away at 63.

0 Comments

image: Little Cancer Risk from Fukushima

Little Cancer Risk from Fukushima

By | March 1, 2013

A new report from the World Health Organization predicts only very minimal increases in cancer risk for residents in the vicinity of the nuclear disaster.

0 Comments

image: Antibody-Drug Combo Approved

Antibody-Drug Combo Approved

By | February 25, 2013

The FDA approves an antibody-drug conjugate that effectively treats a certain type of advanced breast cancer with fewer side effects than previous drugs.

0 Comments

image: Spinning Clinical Trials

Spinning Clinical Trials

By | January 16, 2013

Results of breast cancer drug trials are regularly spun to conceal bias and make the drugs seem more effective or less toxic than they really are.

0 Comments

image: Breast Cancer Pioneer Dies

Breast Cancer Pioneer Dies

By | January 3, 2013

Elwood Jensen, whose research inspired new treatments for breast cancer, has passed away at age 92.

0 Comments

image: Waking Cancer Cells

Waking Cancer Cells

By | December 1, 2012

A protein called Coco rouses dormant breast cancer cells in the lung.

0 Comments

image: Breast Cancer Screening Saves Lives

Breast Cancer Screening Saves Lives

By | November 2, 2012

An expert panel finds that the benefits of breast cancer screening outweigh risks that the procedure will lead to unnecessary treatments.

1 Comment

image: Cancer-Enhancing Stress

Cancer-Enhancing Stress

By | July 17, 2012

Depression in post-op breast cancer patients can cause tumors to establish in bone.

8 Comments

image: A Plea to the FDA

A Plea to the FDA

By | June 21, 2012

Protesters crash the BIO conference to protest the delayed approval of a breast cancer drug.

2 Comments

image: FDA OKs Early Stage Trials

FDA OKs Early Stage Trials

By | June 5, 2012

The regulatory agency will allow early-stage breast cancer patients to try experimental drugs previously reserved for those with advanced disease.

1 Comment

Popular Now

  1. Major German Universities Cancel Elsevier Contracts
  2. Grass Routes
    Features Grass Routes

    Researchers are discovering a suite of new locations and functions of endocannabinoid receptors that play roles in sickness and in health.

  3. Studies Retracted After UCLA Investigation
  4. Trump Nominates Sam Clovis to Lead USDA Research
AAAS